Skip to main content

HB 172 (2023)

Review redundancy in Prescription Drug Affordability Board duties


Directs the Department of Administrative Services, the Insurance Department, and the Department of Health and Human Services to review potential redundancies between existing programs and the Prescription Drug Affordability Board. This bill also directs the Oversight Committee on Health and Human Services to undertake a similar review. Lastly, this bill suspends some of the legal authority of the board for fiscal year 2024.

Bill Sponsor:
Jess Edwards
Republican party logo
Bill Became Law?:
Status Detail:
Killed in the House
Public Hearing Date:
01/26/2023 10:00 am
Public Hearing Location:
LOB Room 302-304
House Voting Date:
Thank you to our sponsors and donors